ÂÜÀòÂÒÂ×

Marc Rivière is currently the General Partner at TVM Capital, and also a Partner at MRCL Inc., focusing on drug development and health care management. Prior to these roles, Marc held various high-level positions in companies such as Aptalis Pharma, Caprion Pharma Inc., Bioniche Life Sciences, Xenon Pharmaceuticals Inc., Planet Medica SA, Aeterna Laboratories Inc, and Benefit Canada Inc./Quintiles Canada Inc. Marc's educational background includes a Doctor of Medicine degree from Université Paul Sabatier Toulouse III and Université de Bordeaux, with a specialization in Tropical Medicine.